Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Business Tribune.
Press releases published on August 7, 2025

Vestis Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. August 8, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vestis Corporation ("Open Lending" or the "Company") (NYSE: VSTS) investors of a class …

Pattern Computer Granted Indian Patent for Novel Cancer Therapy Candidate PCI020302
REDMOND, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, today announced that the Indian Patent Office has granted a new patent titled "Therapeutic Compositions and …

Biodesix Announces Second Quarter 2025 Results and Highlights
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85 million; Conference Call and Webcast Today at 4:30 p.m. …

Pixalate’s July 2025 United Kingdom Publisher Rankings: Top Mobile ‘Gaming’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store
London, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the United Kingdom July 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the …

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John …

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional …

Trupanion Reports Second Quarter 2025 Results
SEATTLE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2025. “The second quarter was one of the …

Trisura Group Reports Second Quarter 2025 Results: 21% Growth in BVPS and Significant Progress in Surety Expansion
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the second quarter of 2025. David Clare, President and CEO of Trisura, …

Runway Growth Finance Corp. Reports Second Quarter 2025 Financial Results
Delivered Total and Net Investment Income of $35.1 million and $13.9 million, Respectively Investment Portfolio of $1.0 billion Conference Call Today, Thursday, August 7, 2025 at 5:00 p.m. ET MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Runway …

Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash …

NCS Multistage Holdings, Inc. to Participate in Upcoming Investor Conferences
HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) announced today that Ryan Hummer, Chief Executive Officer, is scheduled to present in the following upcoming investor conferences: EnerCom …

INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its …

Allbirds Reports Second Quarter 2025 Financial Results
Delivers Second Quarter Results in Line with and Above Guidance Ranges Revises Full Year 2025 Revenue Outlook and Reiterates Adjusted EBITDA Guidance Product, Marketing and Customer Experience Initiatives Expected to Fuel Revenue Growth in Q4 2025 SAN …

Resolute Holdings Reports Second Quarter 2025 Results
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Resolute Holdings Management, Inc. (“Resolute Holdings”) (Nasdaq: RHLD), an operating management company responsible for providing management services to CompoSecure Holdings, L.L.C. (“CompoSecure Holdings”), a …

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025
FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June …

Westrock Coffee Company Reports Second Quarter 2025 Results and Reaffirms 2025 and 2026 Outlook
LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the second quarter ended June 30, 2025. Second Quarter Highlights¹ Consolidated Results …

Rackspace Technology Reports Second Quarter 2025 Results
Revenue of $666 million in the Second Quarter, down 3% Year-over-Year Private Cloud Revenue was $250 million, down 4% Year-over-Year Public Cloud Revenue was $417 million, down 2% Year-over-Year Second Quarter 2025 Cash Flow From Operating Activities was $ …

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …

Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today announced the strategic appointments of two …

Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with updates expected at 9 and 12 month data follow-up. …